• Contact
  • Svenska
Genomic Medicine Sweden
  • Disease areas
    • Childhood cancer
    • Complex diseases
    • Hematology
    • Infectious diseases
    • Pharmacogenomics
    • Rare diseases
    • Solid tumours
  • Collaboration
    • Academia and infrastructures
    • Clinical studies
    • Healthcare providers and authorities
    • Industry
    • International
    • Patient organizations
    • SciLifeLab
  • IT-Informatics
    • IT – Informatics
    • Bioinformatics Analysis Tools
    • National Genomics Platform
    • Development projects and pilot studies
  • News
  • About us
    • About us
    • Organisation & governance
Select Page
Sequencing of 7,000 genomes in Swedish clinical practice in 2021 for better diagnosis and treatment

Sequencing of 7,000 genomes in Swedish clinical practice in 2021 for better diagnosis and treatment

11 April, 2022 | News

In 2021, analyzes were performed of 5,000 samples with whole genome sequencing and almost 2,000 samples with whole exome sequencing in clinical routine in Sweden. The majority of these analyzes were performed for the diagnosis of patients with rare diseases. In...
More news in Swedish
Events in Swedish

Arkiv

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
Genomic Medicine Sweden logo

Genomic Medicine Sweden
c/o Research and development Unit
Department for Healthcare Governance
298 89 Kristianstad
Sweden

  • About us
  • News
  • Contact

Genomic Medicine Sweden (GMS) is a national infrastructure in precision medicine with a vision to implement precision medicine into clinical settings and strengthen the collaboration between Swedish healthcare, research and life-science industry. GMS is comprised of seven regions with university hospitals and universities with a medical faculty. Together with patient organizations, healthcare providers, universities and industry, GMS aims to translate genomic innovation, based on advanced next-generation sequencing technologies, enabling greater precision in the diagnosis, treatment and management of patients with rare disease, cancer and infectious diseases.

Follow us

© Genomic Medicine Sweden - Alla rättigheter förbehållna

Hantera samtycke

För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.

Anpassa samtycke

För att ge den bästa upplevelsen använder vi teknologier som cookies för att lagra och/eller få åtkomst till enhetsinformation. Genom att samtycka till dessa teknologier kan vi behandla data såsom surfbeteende eller unika ID:n på denna webbplats.